Gemini Bioproducts, a supplier of cell culture solutions, has highlighted its effort to help support COVID-19 research.
To support labs pivoting to COVID-19 research, Gemini Bio is prioritizing products and services to assist its customers in four key areas: (1) cell culture, (2) viral harvesting and transport, (3) research tools, and (4) analytical instruments.
Four Key Areas and Products by Area.
Gemini carries gold-standard cell and protein analysis instrumentation through its line of Moxi products. The Moxi Go has the potential to enable simultaneous, rapid analysis of antibodies and cytokines tied to COVID-19. The Moxi Go combines highly accurate and precise cell counting and volumetric sizing with the cell and protein analysis capabilities of a flow cytometer.
The company says the Moxi Go instrument is differentiated by its accuracy, its small footprint for easy deployment, its speed—with tests running in less than 20 seconds—and its ability to calibrate every test independently. The instrument has a touchscreen for easy, intuitive use so that technicians will be able to easily navigate the system menus. In addition, the instrument is fully self-contained, requiring no cleaning fluids or maintenance, making it ideal for cell culture suites, BSL2/3/4 settings with limited space.
CPhI China 2020 To Be Postponed to Dec. 16-18th,
Register as Visitor to the 20th Edition of CPhI China!
-----------------------------------------------------------------------
Editor's Note:
En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,
please email: Julia.Zhang@imsinoexpo.com to motify or remove the content.
(All Rights Reserved)